Yazdan Yazdanpanah Selected Research

Hypertension (High Blood Pressure)

1/2019	Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals.
7/2011	Risk factors of chronic kidney disease in HIV-infected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yazdan Yazdanpanah Research Topics

Disease

40	Infections 04/2024 - 01/2007
29	COVID-19 03/2024 - 01/2020
17	HIV Infections (HIV Infection) 02/2024 - 12/2002
6	Osteomyelitis 10/2010 - 10/2004
5	Fibrosis (Cirrhosis) 01/2017 - 01/2013
5	Acquired Immunodeficiency Syndrome (AIDS) 09/2012 - 12/2002
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023 - 01/2016
4	Neoplasms (Cancer) 01/2023 - 10/2007
4	Coinfection 01/2022 - 07/2015
4	Disease Progression 01/2020 - 01/2005
4	Hepatitis C 10/2018 - 02/2012
3	Bacterial Infections (Bacterial Infection) 01/2023 - 02/2020
3	Ebola Hemorrhagic Fever 01/2021 - 03/2016
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 01/2010
3	Human Influenza (Influenza) 03/2016 - 10/2009
2	Virus Diseases (Viral Diseases) 01/2023 - 02/2020
2	Tuberculosis (Tuberculoses) 01/2022 - 03/2016
2	Pneumonia (Pneumonitis) 01/2022 - 09/2020
2	Chronic Renal Insufficiency 01/2022 - 01/2016
2	Critical Illness (Critically Ill) 09/2020 - 09/2012
2	Hepatitis B 01/2019 - 11/2017
2	Substance-Related Disorders (Drug Abuse) 01/2019 - 04/2015
2	Inflammation (Inflammations) 01/2019 - 01/2019
2	Hypertension (High Blood Pressure) 01/2019 - 07/2011
2	Abscess 01/2019 - 04/2015
2	Communicable Diseases (Infectious Diseases) 02/2017 - 01/2017
2	Chronic Hepatitis C 11/2016 - 01/2016
2	Viremia 03/2016 - 01/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013 - 02/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2010 - 08/2006
2	Thrombocytopenia (Thrombopenia) 10/2010 - 10/2004
2	Catheter-Related Infections 03/2009 - 10/2007
2	Opportunistic Infections (Opportunistic Infection) 01/2007 - 03/2003
1	Superinfection 05/2024
1	Weight Gain 02/2024
1	Ulcer 11/2023

Drug/Important Bio-Agent (IBA)

8	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 10/2004
8	Antiviral Agents (Antivirals)IBA 09/2023 - 10/2009
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2005
7	remdesivirIBA 03/2024 - 01/2020
7	VaccinesIBA 02/2023 - 04/2011
6	Ritonavir (Norvir)FDA Link 01/2023 - 11/2003
5	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 11/2023 - 12/2022
5	Linezolid (Zyvox)FDA Link 01/2023 - 10/2004
5	bedaquiline (R207910)IBA 01/2022 - 01/2016
5	Lamivudine (Epivir)FDA Link 01/2022 - 01/2007
5	NucleosidesIBA 01/2022 - 05/2007
5	Rilpivirine (TMC-278)IBA 09/2021 - 01/2015
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2020
4	Raltegravir Potassium FDA Link 01/2022 - 10/2009
4	Reverse Transcriptase InhibitorsIBA 01/2022 - 05/2007
4	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 05/2007
4	Emtricitabine (Emtriva)FDA Link 01/2019 - 01/2017
4	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018 - 08/2005
4	Tenofovir (Viread)FDA Link 11/2017 - 01/2017
3	Lopinavir FDA Link 01/2023 - 11/2003
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 10/2010
3	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 07/2015
3	AntigensIBA 11/2021 - 07/2020
3	Alanine Transaminase (SGPT)IBA 09/2020 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2007
3	Zidovudine (Retrovir)FDA LinkGeneric 07/2016 - 01/2007
2	Foscarnet FDA LinkGeneric 04/2024 - 07/2016
2	Neutralizing AntibodiesIBA 02/2023 - 06/2022
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2022
2	dolutegravirIBA 01/2022 - 01/2019
2	islatravirIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2013
2	FluoroquinolonesIBA 01/2022 - 01/2016
2	doravirineIBA 01/2022 - 01/2021
2	efavirenz (Sustiva)FDA Link 01/2022 - 03/2011
2	cabotegravirIBA 09/2021 - 09/2017
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 01/2021
2	InterferonsIBA 01/2020 - 07/2015
2	SiliconesIBA 01/2019 - 01/2019
2	OPC-67683IBA 01/2018 - 03/2016
2	SofosbuvirIBA 11/2016 - 01/2016
2	favipiravirIBA 04/2016 - 03/2016
2	Vancomycin FDA LinkGeneric 06/2011 - 03/2009
2	CalciumIBA 12/2009 - 04/2008
2	fosamprenavir (Lexiva)FDA Link 11/2008 - 01/2007
2	A-factor (Streptomyces)IBA 04/2008 - 08/2007
1	ibalizumabIBA 04/2024
1	cilgavimab and tixagevimab drug combinationIBA 02/2024
1	tixagevimabIBA 02/2024
1	cilgavimabIBA 02/2024
1	lamivudine drug combination abacavir FDA Link 02/2024
1	baricitinibIBA 10/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 02/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 02/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023

Therapy/Procedure

29	Therapeutics 02/2024 - 03/2003
6	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 12/2002
2	Salvage Therapy 04/2024 - 07/2016
2	Length of Stay 01/2021 - 06/2008
2	Aftercare (After-Treatment) 01/2020 - 01/2017
2	Condoms (Condom) 01/2018 - 03/2013
2	Art Therapy 01/2017 - 01/2010
2	Antibiotic Prophylaxis 03/2009 - 08/2007
2	Catheters 03/2009 - 10/2007